Finance

Beta
Lists
PDSB:NASDAQ
PDS Biotechnology Corp
$1.10
-9.43%
(-0.12) 1D
Jun 5, 11:40:20 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PDSB...
Open
$1.20
High
$1.25
Low
$1.09
Mkt. cap
61.68M
Avg. vol.
1.08M
Volume
621.77K
52-wk high
$1.92
52-wk low
$0.51
EPS
-$0.68
Beta
1.57
Shares outstanding
55.82M
No. of employees
21
Open
$1.20
High
$1.25
Low
$1.09
Mkt. cap
61.68M
Avg. vol.
1.08M
Volume
621.77K
52-wk high
$1.92
52-wk low
$0.51
EPS
-$0.68
Beta
1.57
Shares outstanding
55.82M
No. of employees
21
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to PDSB in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for PDSB in the last 3 months.
Highest
Current $1.10
$15.00 (+1,257.47%)
Average
$7.50 (+578.73%)
Lowest
$3.00 (+171.49%)
News stories
From sources across the web
About PDS Biotechnology Corp
CEO-
Employees21
Founded2005
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.21M
4.58M
4.41M
3.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.41M
3.56M
2.27M
3.06M
Operating expense
7.62M
8.14M
6.67M
6.52M
Total operating expenses
7.62M
8.14M
6.67M
6.52M
Operating income
-7.62M
-8.14M
-6.67M
-6.52M
Other non operating income
-
-
-
-
EBT including unusual items
-9.43M
-9.01M
-7.56M
-7.35M
EBT excluding unusual items
-9.43M
-9.01M
-7.56M
-7.35M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.43M
-9.01M
-7.56M
-7.35M
Net profit margin
-
-
-
-
Earnings per share
-0.21
-0.19
-0.14
-0.13
Interest and investment income
333.62K
281.11K
224.66K
186.81K
Interest expense
-2.14M
-1.15M
-1.11M
-1.01M
Net interest expenses
-1.81M
-869.27K
-888.21K
-827.97K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.61M
-8.13M
-6.66M
-6.51M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more